These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

202 related items for PubMed ID: 12065345

  • 1. Clinically important improvements in asthma-specific quality of life, but no difference in conventional clinical indexes in patients changed from conventional beclomethasone dipropionate to approximately half the dose of extrafine beclomethasone dipropionate.
    Juniper EF, Price DB, Stampone PA, Creemers JP, Mol SJ, Fireman P.
    Chest; 2002 Jun; 121(6):1824-32. PubMed ID: 12065345
    [Abstract] [Full Text] [Related]

  • 2. Long-term safety and efficacy of a chlorofluorocarbon-free beclomethasone dipropionate extrafine aerosol.
    Fireman P, Prenner BM, Vincken W, Demedts M, Mol SJ, Cohen RM.
    Ann Allergy Asthma Immunol; 2001 May; 86(5):557-65. PubMed ID: 11379808
    [Abstract] [Full Text] [Related]

  • 3. Switching from conventional to extrafine aerosol beclomethasone dipropionate therapy in children: a 6-month, open- label, randomized trial.
    Szefler SJ, Warner J, Staab D, Wahn U, Le Bourgeois M, van Essen-Zandvliet EE, Arora S, Pedersen S, Pediatric Study Group.
    J Allergy Clin Immunol; 2002 Jul; 110(1):45-50. PubMed ID: 12110818
    [Abstract] [Full Text] [Related]

  • 4. Health-related quality of life in moderate asthma: 400 microg hydrofluoroalkane beclomethasone dipropionate vs 800 microg chlorofluorocarbon beclomethasone dipropionate. The Study Group.
    Juniper EF, Buist AS.
    Chest; 1999 Nov; 116(5):1297-303. PubMed ID: 10559091
    [Abstract] [Full Text] [Related]

  • 5. Hydrofluoroalkane-134a beclomethasone dipropionate, 400 microg, is as effective as chlorofluorocarbon beclomethasone dipropionate, 800 microg, for the treatment of moderate asthma.
    Gross G, Thompson PJ, Chervinsky P, Vanden Burgt J.
    Chest; 1999 Feb; 115(2):343-51. PubMed ID: 10027430
    [Abstract] [Full Text] [Related]

  • 6. Growth, systemic safety, and efficacy during 1 year of asthma treatment with different beclomethasone dipropionate formulations: an open-label, randomized comparison of extrafine and conventional aerosols in children.
    Pedersen S, Warner J, Wahn U, Staab D, Le Bourgeois M, Van Essen-Zandvliet E, Arora S, Szefler SJ, Pediatric Study Group.
    Pediatrics; 2002 Jun; 109(6):e92. PubMed ID: 12042586
    [Abstract] [Full Text] [Related]

  • 7. Hydrofluoroalkane-134a beclomethasone dipropionate extrafine aerosol provides equivalent asthma control to chlorofluorocarbon beclomethasone dipropionate at approximately half the total daily dose.
    Davies RJ, Stampone P, O'Connor BJ.
    Respir Med; 1998 Jun; 92 Suppl A():23-31. PubMed ID: 9850360
    [Abstract] [Full Text] [Related]

  • 8. The cost effectiveness of chlorofluorocarbon-free beclomethasone dipropionate in the treatment of chronic asthma: a cost model based on a 1-year pragmatic, randomised clinical study.
    Price D, Haughney J, Duerden M, Nicholls C, Moseley C.
    Pharmacoeconomics; 2002 Jun; 20(10):653-64. PubMed ID: 12162754
    [Abstract] [Full Text] [Related]

  • 9. Safety and efficacy of HFA-134a beclomethasone dipropionate extra-fine aerosol over six months.
    Boulet LP, Cartier A, Ernst P, Larivée P, Laviolette M.
    Can Respir J; 2004 Mar; 11(2):123-30. PubMed ID: 15045043
    [Abstract] [Full Text] [Related]

  • 10. Effectiveness of low doses (50 and 100 microg b.i.d) of beclomethasone dipropionate delivered as a CFC-free extrafine aerosol in adults with mild to moderate asthma. Study Group.
    Hampel F, Lisberg E, Guérin JC.
    J Asthma; 2000 Aug; 37(5):389-98. PubMed ID: 10983616
    [Abstract] [Full Text] [Related]

  • 11. Efficacy response of inhaled beclomethasone dipropionate in asthma is proportional to dose and is improved by formulation with a new propellant.
    Busse WW, Brazinsky S, Jacobson K, Stricker W, Schmitt K, Vanden Burgt J, Donnell D, Hannon S, Colice GL.
    J Allergy Clin Immunol; 1999 Dec; 104(6):1215-22. PubMed ID: 10589004
    [Abstract] [Full Text] [Related]

  • 12. Improved control of asthma symptoms with a reduced dose of HFA-BDP extrafine aerosol: an open-label, randomised study.
    Ederle K, Multicentre Study Group.
    Eur Rev Med Pharmacol Sci; 2003 Dec; 7(2):45-55. PubMed ID: 12911119
    [Abstract] [Full Text] [Related]

  • 13. Efficacy of HFA-beclomethasone dipropionate extra-fine aerosol (800 microg day(-1)) versus HFA-fluticasone propionate (1000 microg day(-1)) in patients with asthma.
    Aubier M, Wettenger R, Gans SJ.
    Respir Med; 2001 Mar; 95(3):212-20. PubMed ID: 11266239
    [Abstract] [Full Text] [Related]

  • 14. Therapeutic equivalence of inhaled beclomethasone dipropionate with CFC and non-CFC (HFA 134a) propellants both delivered via the Easibreathe inhaler for the treatment of paediatric asthma.
    Farmer IS, Middle M, Savic J, Perri VL, Herdman MJ.
    Respir Med; 2000 Jan; 94(1):57-63. PubMed ID: 10714480
    [Abstract] [Full Text] [Related]

  • 15. Efficacy and safety of once or twice daily inhalation of extrafine HFA beclomethasone dipropionate in patients with mild to moderate asthma.
    Gillissen A, Richter A, Oster H, Criée CP.
    J Physiol Pharmacol; 2007 Nov; 58 Suppl 5(Pt 1):233-41. PubMed ID: 18204133
    [Abstract] [Full Text] [Related]

  • 16. Equivalent asthma control after dose reduction with HFA-134a beclomethasone solution aerosol. Comparative Inhaled Steroid Investigation Group (CISIG).
    Magnussen H.
    Respir Med; 2000 Jun; 94(6):549-55. PubMed ID: 10921758
    [Abstract] [Full Text] [Related]

  • 17. Asthma control with extrafine-particle hydrofluoroalkane-beclometasone vs. large-particle chlorofluorocarbon-beclometasone: a real-world observational study.
    Barnes N, Price D, Colice G, Chisholm A, Dorinsky P, Hillyer EV, Burden A, Lee AJ, Martin RJ, Roche N, von Ziegenweidt J, Israel E.
    Clin Exp Allergy; 2011 Nov; 41(11):1521-32. PubMed ID: 21752116
    [Abstract] [Full Text] [Related]

  • 18. Inhaled beclomethasone versus placebo for chronic asthma.
    Adams NP, Bestall JB, Malouf R, Lasserson TJ, Jones PW.
    Cochrane Database Syst Rev; 2005 Jan 25; 2005(1):CD002738. PubMed ID: 15674896
    [Abstract] [Full Text] [Related]

  • 19. [Influence of changing from chlorofluorocarbon (CFC)-beclomethasone dipropionate (BDP) to hydrofluoroalkane (HFA)-BDP on pulmonary function in asthmatic children].
    Yoshida Y, Inoue T, Nishikido T, Kameda M, Takamatu I, Doi S.
    Arerugi; 2007 Dec 25; 56(12):1502-9. PubMed ID: 18195554
    [Abstract] [Full Text] [Related]

  • 20. Equivalence of asthma control with new CFC-free formulation HFA-134a beclomethasone dipropionate and CFC-beclomethasone dipropionate.
    Dahl R, Ringdal N, Ward SM, Stampone P, Donnell D.
    Br J Clin Pract; 1997 Dec 25; 51(1):11-5. PubMed ID: 9158265
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.